Series A

Orum Therapeutics adds deep clinical and dealmaking expertise to its board, signaling a strategic acceleration of its innovative DAC pipeline for cancer.

With a fresh $12M in funding, Canadian fintech Common Wealth is using AI and a modern platform to bring retirement plans to underserved small businesses.

A high-level visit to General Atomics signals a major U.S. push for fusion energy, blending private innovation with public funding to win a global race.

A new partnership combines local infrastructure with global expertise, aiming to streamline development for startups and solidify Singapore's biotech leadership.

A new company is selling franchises to doctors and pharmacists, promising to cut out insurers and restore local care. But can this bold model survive the system?

Five new clinical trials in Chicago repurpose existing drugs for PTSD, cancer, and more, offering a faster, cheaper path to treating unsolved diseases.

Brands are disappearing from new AI search engines. A new discipline called 'Machine Relations' aims to solve this 'AI invisibility' crisis.

Evaline Tsai's promotion at Gigascale Capital highlights a new VC playbook where deep scientific expertise is crucial for funding our physical economy's future.

A Swiss biotech's novel antibiotic has entered human trials with new funding, offering a fresh hope against the world's most dangerous superbugs.

Ann Arbor startup Adrenaline Interactive lands a $1M prize to revolutionize in-game ads, signaling Michigan's push to become a tech innovation hub.

A small environmental firm unveils a plan to upend global markets with a fraud-proof 'Physical Truth Infrastructure.' But can it deliver on its promises?

Miami startup Petwealth emerges from stealth with at-home PCR tests and key partnerships, aiming to revolutionize the $200B pet health industry.

MTI replaces its Road Tour with an intense, invite-only forum, uniting top regulators and experts to find the next wave of healthcare solutions.

Khloé Kardashian's Khloud brand expands with new Protein Chips, leveraging celebrity power and a strategic Target partnership to disrupt the snack market.

After 11 straight quarters of growth, clean nail care pioneer MiniLuxe lands new funding. Discover how its tech-driven, ethical model is winning.

With its lead drug for a rare pediatric liver disease entering late-stage trials, NorthSea Therapeutics adds a veteran drug developer to its board.

The fast-casual chain brings its green mission and reusable bowls to suburban Chicago, targeting a health-conscious market with community-focused initiatives.

New research shows parents welcome corporate sponsors in schools to fill funding gaps, creating a powerful new marketing channel built on community trust.

A major partnership is set to unlock Yukon's Stikine Terrane, as Agnico Eagle invests millions in Cascadia Minerals to fund a massive exploration push.

Fueled by a $250K grant from Allen Family Philanthropies, a new pilot aims to tackle Seattle's infamous social isolation with a structured national plan.